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Abstract.  Human chorionic gonadotropin (hCG)  is a 
member of a  family of heterodimeric glycoprotein hor- 
mones that have a common ct subunit but differ in 
their hormone-specific 13 subunit.  Site-directed muta- 
genesis of the two asparagine-linked  glycosylation sites 
of hCGct was used to study the function of the in- 
dividual oligosaccharide chains in  secretion and 
subunit assembly.  Expression vectors for the ~t genes 
(wild-type and mutant) and the hCG[3 gene were con- 
structed and transfected into Chinese hamster ovary 
cells.  Loss of the oligosaccharide at position 78 causes 
the mutant subunit to be degraded quickly and <20% 
is secreted.  However, the presence of hCG[3  stabilizes 
this  mutant and allows  ~45%  of the subunit  in the 
form of a dimer to exit the cell.  Absence of carbohy- 
drate at asparagine 52 does not perturb the stability or 
transport of the ct subunit but does affect dimer secre- 
tion;  under conditions where this  mutant or hCGI3 was 
in excess, <30%  is secreted in the form of a  dimer. 
Mutagenesis of both glycosylation sites affects mono- 
mer and dimer secretion but at levels intermediate be- 
tween the single-site mutants.  We conclude that there 
are site-specific functions of the hCGct asparagine- 
linked oligosaccharides with  respect to the stability 
and assembly of hCG. 
H 
UMAN chorionic gonadotropin (hCG) ~ is a member 
of the glycoprotein hormone family which includes 
lutropin,  follitropin,  and  thyrotropin.  These  hor- 
mones are heterodimers consisting of an ct subunit that is 
common among the four hormones,  and  a  13  subunit that 
gives each  its  unique  biological activity (5,  36,  53).  The 
hCGa subunit contains two asparagine (Asn)-linked oligo- 
saccharide chains (13, 23), whereas the hCG13 subunit con- 
tains two Asn-linked and four serine O-linked carbohydrate 
units (3, 22,  24). 
Several studies have addressed the role of the Asn-linked 
oligosaccharide chains on the gonadotropins.  Chemical or 
enzymatic methods have been used to remove all or part of 
the oligosaccharide chains to obtain a better understanding 
of carbohydrate function. While desialylation of hCG causes 
it to be rapidly cleared via the hepatic route (32), its effects 
on  biological  activity  in  vitro  are  not  clear  (1,  33,  51). 
Removal of carbohydrate internal to sialic acid or complete 
deglycosylation converts hCG  into an antagonist;  it binds 
more tightly to its receptor, but shows decreased biological 
activity in  vitro (6,  21,  25,  33).  Although  the  role of the 
oligosaccharide side-chains in folding and assembly of the 
hCG subunits in vivo is unknown, it has been postulated that 
1. Abbreviations used in this paper:  Asn, asparagine; CHO. Chinese ham- 
ster ovary; Endo F, Endoglycosidase F; Endo H, Endoglycosidase H; hCG, 
human chorionic gonadotropin; Thr, threonine. 
these  oligosaccharides are  important  for correct disulfide 
bond formation (48). Combination of hCG subunits appar- 
ently occurs when the oligosaccharides are removed chemi- 
cally (21, 25) or enzymatically (16). However, one problem 
with these methods is that incompletely deglycosylated de- 
rivatives are  generated;  in  addition,  such  procedures can 
cause denaturation and/or dissociation of the subunits,  and 
therefore alter the hormone in other ways not related to car- 
bohydrate removal. 
The most common method to prevent Asn-linked glycosy- 
lation is with tunicamycin which blocks the synthesis of the 
lipid-carbohydrate carrier complex (49). The problems with 
this  approach are  that  individual  carbohydrate units  on a 
multiglycosylated protein cannot be examined, and indirect 
effects of tunicamycin could affect secretion of the glycopro- 
tein. We have used oligonucleotide-directed mutagenesis to 
investigate the role of the individual Asn-linked oligosaccha- 
rides on hCGct in  secretion and assembly  in  vivo.  Using 
DNA-mediated transfer techniques, we have transfected vec- 
tors containing wild-type and mutant hCG~t genes into Chi- 
nese hamster ovary (CHO) cells and selected lines express- 
ing the various  subunits.  We have also  co-transfected the 
hCG13 construct with the wild-type and mutant hCGa genes 
to examine assembly in vivo. Using site-directed mutagene- 
sis  of the  hCGct  glycosylation sites,  removal of a  single 
oligosaccharide enhances degradation whereas loss of the 
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Figure I.  Engineering of hCGct 
gene and hCG expression vectors. 
A  shows  the  construction  of an 
hCG~t  minigene.  The  hCG~t 
eDNA protein coding  sequence 
(crosshatched box)  is  bordered 
by two unique restriction enzyme 
sites,  Barn  HI  and  Xho  I.  The 
third and fourth exons (solid  boxes) 
of the hCGot gene were isolated 
on one Eco RI (Rl)-Xho I frag- 
ment. The Xba I-Xho I fragment 
from the hCGet gene was inserted 
into the Xba I-Xho I sites of the 
hCGa cDNA-containing plasmid 
(4, 38), resulting in a 2.4-kb mini- 
gene maintaining the correct read- 
ing frame of the coding sequence. 
This  ct minigene construct con- 
tains  two  coding  regions (Exon 
2+3 and Exon 4), a single intron 
and polyadenylation signals 3' to 
exon 4.  This intron contains the 
identical splice signals which are 
in the original hCG~t gene.  The 
construction of the expression vec- 
tors pM2CGct  and pM2CG[3 (B) 
are  described  in  Materials  and 
Methods and reference 29. In brief, 
hCG[3 and hCGa  genes  (a-WT, 
0tAAsnl, aAAsn2, aAAsn[l+2], 
aAThr2, and otAThr[l+2]) were 
inserted into the  single Barn  HI 
restriction enzyme  site  in  pM  2 
downstream of the Harvey murine 
sarcoma  virus  (HaMuSV)  long 
terminal repeat (LTR) (ll) (arrow). 
pM  2 is a pSV2neo derivative (47) 
which  contains  the  Amp  R gene 
(crosshatched box) and the Neo  R 
gene (open box) for selection with 
the  neomycin  analogue,  G418. 
Coding regions of the hCGa and 
hCG[3 genes are denoted by the 
dark boxes. 
other oligosaccharide alters the secretion of dimer. The loss 
of both oligosaccharides affects both secretion and dimeriza- 
tion but at intermediate levels between the single-site mu- 
tants.  We conclude that there are site-specific intracellular 
functions of the two  Asn-linked oligosaccharide chains on 
hCGct. 
Materials and Methods 
Enzymes used to prepare vectors were purchased from New England Bio- 
labs, Beverly, MA; Bethesda Research Laboratories, Gaithersburg, MD; or 
Boehringer Mannheim Diagnostics, Inc., Houston, TX. Klenow fragment 
was a gift from Dr. John Majors, Washington University, St.  Louis, MO. 
The DNA vector, MI3 UM20 (30), was obtained from International Bio- 
technologies, Inc.,  New Haven,  CT.  Oligonucleotides used for the site- 
directed mutagenesis were prepared by the Washington University Sequenc- 
ing Facility,  St. Louis, MO. Cell culture media and reagents were prepared 
by the Washington University Center for Basic Cancer Research, St. Louis, 
MO. Dialyzed calf serum and the neomycin analogue, G418, were purchased 
from Gibco Laboratories,  Grand Island,  NY.  FCS  was  purchased from 
Hazelton Systems, Inc., Aberdeen, MD; and Pansorbin, a Staphylococcus 
aureus  membrane  preparation,  from  Behring  Diagnostics,  American 
Hoechst Corp., San Diego, CA. 135S]Cysteine (>1,000  Ci/mmol) was pur- 
chased from Amersham Corp., Arlington Heights, IL. Endoglycosidase H 
(Endo H) (lot No. 0019) was obtained from Miles Laboratories, Naperville, 
IL, and Endoglycosidase F (Endo F) was a gift from Dr. Jacques Baenziger, 
Washington University, St. Louis, MO.  Tunicamycin was purchased from 
Calbiochem-Behring Corp.,  La Jolla,  CA.  All other reagents were pur- 
chased from Sigma Chemical Company, St.  Louis, MO. 
Gene and Vector Constructions 
Construction of the hCGa minigene is described in the legend to Fig. I. This 
recombinant was constructed because of the much lower protein expression 
of the eDNA in other constructs (data not shown) and because the hCGo 
gene was too large to insert into pM-'. pM: was constructed by ligating  an 
Eco R1-Bam H1 fragment from pDVXR (obtained from C. Hardy and M. 
Botchan,  University of California,  Berkeley,  CA) containing the Harvey 
murine sarcoma virus long terminal repeat (11) into the Eco RI  and Bam 
H1  sites of pSV2neo (47).  pM2CG~  was constructed by inserting a  Bgl 
II-Bam HI fragment containing the hCGB gene (37) into the single Bam HI 
site in pM 2 (see Fig.  1 B and reference 29).  pM2CGct and the mutant de- 
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pM2otAThr2,  and  pMZ0tAThr(l+2)  were constructed by  inserting Bam- 
Bgl II fragments containing the wild-type hCGct (Fig.  1 A) and the mutant 
hCGct genes (not shown) into the compatible Barn  H1  site in pM-'.  The 
mutant genes were derived from mutagenesis of the hCGct fusion gene that 
had been inserted into M13 UM20 (see below). 
Site-directed Mutagenesis 
The Barn HI-Xho I fragment containing the hCGct fusion gene, as described 
in  Fig.  l,  was ligated into M13  UM20 and the single-stranded viral  re- 
combinant DNA was isolated for mutagenesis. Mutant 22-met oligomers, 
5'-GGTGACG'I~CTTTTGCACCAAC-3' and 5'-CTTAGTGGAGCGGGAT- 
ATG-3',  were synthesized for mutagenesis of the Ash  52 and Ash  TM codons, 
respectively; and  mutant  26-mer  oligomers,  5'-GTGGACTCTGAGGCC- 
ACGTTCTTTTG-3'  and  5'-CAGTGGCACGCCGCATGGTTCTCCAC-3', 
were synthesized for mutagenesis of the corresponding Thr  ~  and Thr  8~ 
codons, respectively. The mutagenesis procedure used was identical to that 
described by Seeburg et al. (44) except for the following modifications. The 
temperature of the annealing reaction was begun at  10~  above the calcu- 
lated Tm and allowed to cool to 10~  below the Tm before placing the reac- 
tion on ice. The DNA synthesis reaction on the recombinant template was 
incubated overnight at 16~  followed by transformation of  competent Esche- 
richia coil K12 JMI09 cells. Hybridization and washing in tetramethylam- 
monium chloride were as described in Wood et al. (55);  the wash tempera- 
ture for the 22-mers was 61~  and for the 26-mers was 67~  All mutant 
phage were further purified and rescreened to ensure that there was no wild- 
type phage contamination before sequencing. The integrity of the gene was 
rechecked by restriction enzyme analysis. The mutation frequency achieved 
was consistently >5%. 
DNA Transfection and Clone Selection 
Plasmids  pM2CG0t,  pM2aAAsnl,  pM2aAAsn2,  pM2aAAsn(l+2), 
pM2txAThrl,  pM2aAThr2, and pM2aAThr(l+2) were transfected alone or 
co-transfected with pM~CG[3 into CHO cells by a modification of the cal- 
cium phosphate method (17, 35, 45). Cells were selected for insertion of the 
plasmid DNA by growing in culture medium containing 0.25 mg/ml of the 
neomycin analogue, G418. Transfected colonies resistant to G418 were har- 
vested ,-oll d after transfection and subsequently screened for the expression 
of hCGct (wild-type and mutant), or hCG dimer (wild-type and mutant) by 
immunoprecipitation of metabolically labeled cells (see below). 
Cell Culture 
The CHO cells were maintained in medium I  (Ham's F12  medium sup- 
plemented with penicillin [100 U/ml], streptomycin [100 I.tg/ml], and gluta- 
mine [2 mM]) containing 5%  (vol/vol) FCS at  37~  in a humidified 5% 
CO,_ incubator.  Transfected clones were maintained in the above culture 
medium supplemented with 0.25  mg/ml active G418. 
Metabolic Labeling 
On day 0, cells were plated into 12-well dishes (350,000  cells/well) in  l ml 
of medium I supplemented with 5% FCS. For continuous labeling experi- 
ments, cells were washed twice with cysteine-free medium II (medium I 
supplemented with 5% dialyzed calf serum) and labeled for 7 or 8 h in  1 
ml of cysteine-free medium II containing 50 laCi/ml  [sSS]cysteine (>l,000 
Ci/mmol). For pulse-chase experiments, the cells were washed twice and 
preincubated for 1.5 h with cysteine-free medium II, followed by a 20-min 
pulse-labeling in cysteine-free medium II containing 100 laCi/ml  [35S]cys- 
teine. The labeled cells were then washed twice with medium II containing 
1 mM unlabeled cysteine and incubated in this chase medium for the indi- 
cated times. 
Immunoprecipitation 
Medium and cell lysate  samples were prepared, immunoprecipitated, and 
treated with endoglycosidases as described (10). Polyclonal antisera against 
hCG0t and hCG[3 were prepared in our laboratory and were also a gift from 
Drs. Steven Birken and Robert Canfield, Columbia University College of 
Physicians and Surgeons, New York, NY. The antiserum used for each ex- 
periment is described in the text. Each antiserum had been titered and was 
added in severalfold excess to ensure complete immunoprecipitation. 
PAGE 
The hCGa, hCG[3, and hCG dimer immunoprecipitates were resolved on 
15% SDS-polyacrylamide gels by the method of Laemmli (26). Gels were 
soaked for 10 min in  1 M sodium salicylate, dried, and autoradiographed 
with preflashed film as described (10). Autoradiographs were scanned with 
an Ultroscan XL laser densitometer (LKB Instruments, Inc., Gaithersburg, 
MD). 
Results 
Site-directed Mutagenesis of  hCGa 
The recognition signal for Asn-linked glycosylation of pro- 
teins is the tripeptide Asn-X-Thr/Ser (18, 19, 28). The hCGa 
subunit contains two glycosylation sites at Asn 52 and 78. 
Oligonucleotide-directed mutagenesis (56) was chosen to ex- 
amine the functional importance of the individual glycosyla- 
tion sites in secretion and subunit assembly. Mutagenesis of 
either the Asn or the Thr amino acids in the Asn-X-Thr recog- 
nition sequence in the hCGa gene would be sufficient to pre- 
vent transfer of the carbodydrate to the a  subunit (18, 19, 28). 
We chose to convert the Ash to aspartic acid residues because 
they are isoterie and have similar hydrogen bond characteris- 
tics (see reference 31). The 5'-AAC-3' triplet coding for Asn 
52  was  converted  to  5'-GAC-3' coding  for  aspartic  acid 
(designated aAAsnl). A similar change was made at position 
78 in a different clone (designated aAAsn2) and a third mu- 
tant gene was constructed in which both sites were mutated 
(designated ~tAAsn[l+2]). The Thr residues in these triplets 
were converted to alanine residues to assess that the results 
from the Ash mutants were due to loss of an oligosaccharide 
and not to alterations in the protein sequence (see reference 
43).  These mutants are designated  0tAThrl,  uAThr2,  and 
ctAThr(l+2)  to  denote  changes  of Thr  54,  Thr  s~  or  both 
Thr's, respectively, to alanine residues. After mutant selec- 
tions,  we sequenced  the mutated regions to verify that the 
changes were correct and that there were no other sequence 
alterations (Fig. 2 A) (42). The wild-type (designated a-WT) 
and mutant hCGa proteins are depicted for ease of represen- 
tation in Fig. 2 B. Construction of these mutants allowed us 
to  examine  the  association  of the  individual  hCGa  Asn- 
linked  oligosaccharides  to  the  secretion,  stability,  and  as- 
sembly of the intact dimer. 
Expression of  hCGa Glycosylation Mutants 
To analyze the synthesis of the wild-type and mutant pro- 
teins,  we inserted these genes into a eukaryotic expression 
vector,  pM  2,  and  transfected  the  resultant  plasmids  into 
CHO  cells.  Stable  clonal  cell  lines  expressing  ct-WT, 
aAAsnl,  etAAsn2,  and  aAAsn(l+2)  were isolated.  These 
cell lines were labeled  in the presence of [ssS]cysteine for 
7 h, and media and cell lysate were analyzed for immunopre- 
cipitable hCGet by SDS-PAGE (Fig. 3).  Except for aAAsn- 
(1+2),  the  intracellular  ("lysate")  hCGa  forms  migrated 
faster than the corresponding extracellular ("medium") form. 
This upward shift in molecular mass upon secretion of wild- 
type hCGa (intracellular, 23 kD; extracellular, 28 kD) is due 
to terminal processing of the  Asn-linked  chains  on  a-WT 
(data not shown) and is most likely responsible for the smaller 
shifts of the secreted forms of ctAAsnl (intracellular, 20 kD; 
extracellular, 22 kD) and ctAAsn2 (intracellular, 20 kD; ex- 
tracellular, 23.5 kD). The change in molecular mass is not 
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Figure 2. Mutagenesis of the hCGa Asn-linked glycosylation sites. 
Dideoxy sequencing (42) was performed on both the wild-type and 
mutant genes (A). Shown here is the conversion of  the Ash 52 codon 
5'-AAC-3' to the aspartic  acid codon 5'-GAC-3'. Identical results 
were achieved for the other mutations. The hCGct proteins contain- 
ing either two (a-WT), one (ctAAsnl, ctAAsn2, aAThrl, aAThr2), 
or zero (aAAsn[l+2] and ctAThr[l+2]) Asn-linked glycosylation 
sites are shown (B).  CHO, the carbohydrate moiety attached to the 
wild-type and mutant hCGet proteins. 
seen upon secretion of the mutant ctAAsn(1 +2) (15 kD) since 
it is devoid of Asn-linked oligosaccharides (data not shown). 
Wild-type hCGct (ct-WT) is expressed at high levels and 
secreted very efficiently into the medium with  severalfold 
more extracellular than intracellular material present, aAAsnl 
is also secreted in large amounts (with more material present 
in  the  medium  than  the  lysate),  but  at  a  level  lower than 
ct-WT.  However, unlike  ct-WT  and  ctAAsnl,  ctAAsn2  and 
aAAsn(l+2) are not secreted into the medium in substantial 
amounts. Removal of the glycosylation sites and not the alter- 
ation in the amino acid is presumably responsible for these 
changes since the Thr~Alanine  mutants give identical  re- 
sults (see below). 
To document that the Asn-linked oligosaccharides on the 
secreted  ct  forms were complex in  structure,  and  that the 
changes in the mobility of the mutated proteins were not due 
to proteolysis, we treated the wild-type and the two mutants, 
ctAAsnl  and 0tAAsn2, with Endo H  (50) and Endo F  (12). 
Endo H cleaves high mannose, noncomplex, and hybrid-type 
oligosaccharides, whereas Endo F cleaves, in addition, com- 
plex oligosaccharides. Immunoprecipitable hCGot from the 
media of clones  expressing ~t-WT, ~tAAsnl,  and  ~tAAsn2 
was  treated  with  Endo  H  or  Endo  F,  and  the  products 
resolved on SDS-PAGE gels (Fig. 4). Scanning densitometry 
revealed that <5 % of the a-WT, aAAsnl, and 0tAAsn2 were 
sensitive to  Endo H.  Wild-type and  mutant material  were 
completely sensitive to  Endo  F,  and  the digested  material 
migrated at approximately the same molecular mass as de- 
glycosylated wild-type ct  (15  kD).  Thus,  >95%  of the  se- 
creted material is resistant to Endo H but sensitive to Endo 
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tion mutants in CHO cells. CHO clones expressing native hCGct 
(a-WT) and Ash-linked glycosylation mutants (ctAAsnl,  az~Asn2, 
and aAAsn[14-2])  were labeled for 7 h with 50 laCi/ml 135S]cys  - 
teine. Aliquots of medium (M) and cell lysate (L) were immunopre- 
cipitated  with  hCGct  antiserum,  and  analyzed  as  described  in 
Materials and Methods. Molecular mass standards (carbonic anhy- 
drase,  30 kD;  soybean trypsin  inhibitor, 21.5 kD; cytochrome C, 
12.5 kD) are shown at the right. 
F, showing that the mutant and native subunits are processed 
to complex-type oligosaccharides and that their presence in 
the medium is due to passage through the normal secretory 
pathway and not due to cell lysis. Also, the Endo F data show 
that changes in mobility of the mutant subunits is due to the 
absence of oligosaccharide rather than proteolysis. 
Secretion Kinetics of hCGa Mutants 
As  described  above,  the  level of secretion  of the  mutants 
differed from wild-type 0t and could be attributed to lower 
Figure 4. Endoglycosidase treatment of  hCGct wild-type and mono- 
glycosylated mutant subunits.  Clones expressing ct-WT, aAAsnl, 
and r  were labeled for 7 h and aliquots of media were immu- 
noprecipitated with hCGtl antiserum before digestion with Endo H 
(H), Endo F (F), or no enzyme (-). Electrophoresis and autora- 
diography were performed as described in Materials and Methods. 
The migration of the doubly glycosylated, monoglycosylated, and 
deglycosylated subunits are indicated by N-2, N-l, and N-O, respec- 
tively. 
levels of expression, increased proteolysis, and/or a block in 
transport or secretion. To distinguish between these possibil- 
ities, pulse-chase experiments were performed on clones ex- 
pressing ct-WT and the individual mutants (both Asn and Thr 
mutants).  Confluent cells were pulse labeled with [35S]cys- 
teine for 20 min, chased with unlabeled c3,steine for the indi- 
cated times, and the intracellular Clysate") and extracellular 
("medium") hCGct  forms were immunoprecipitated with a 
polyclonal hCGct-specific antiserum (Fig. 5). In Fig. 5 A, the 
kinetics  of disappearance of the  intracellular  ct-WT  is  the 
same as that seen for the appearance of ct-WT in the medium 
(t,/2 =  85 min).  Scanning  densitometry confirms that there 
is  >95%  recovery  in  the  medium of a-WT.  These results 
were comparable to pulse-chase studies of wild-type hCG0t 
secreted from C127 mouse mammary tumor cells transfected 
with hCGct (10). 
The  pulse-chase  kinetics  of  ctAAsnl  (Fig.  5  B)  and 
ctAThrl (Fig. 5 C) show identical rates of recovery from the 
cells,  and  their secretion  into the  medium  (t,/~ =  85  min) 
was similar to  wild-type hCGa  (compare with  Fig.  5  A). 
Furthermore, >95 % of ctAAsnl and aAThrl accumulated in 
the medium but,  unlike wild-type ct, these mutant subunits 
migrate at a more homogeneous position on the gel (see Dis- 
cussion) and the secreted forms show less of an upward shift 
(only 2 kD). Thus, the absence of the oligosaccharide at Asn 
52 by mutation of either the Asn or Thr residues does not 
affect either its secretion rate nor its recovery in the medium. 
Since ctAAsnl and ct-WT show no differences in secretion or 
degradation rates,  the different secretion levels of aAAsnl 
and a-WT seen in Fig. 3 must be attributed to clonal varia- 
tion in expression. 
In contrast to the kinetics of aAAsnl, aAThrl, and ct-WT, 
mutagenesis of the second glycosylation site (ctAAsn2 and 
ctAThr2) markedly affects the behavior of the protein (Fig. 
5, D  and E).  Densitometric scanning of the autoradiograph 
indicates that the intracellular ctAAsn2 and ctAThr2 subunits 
disappear  with  similar  kinetics  as  ct-WT,  ctAAsnl,  and 
ctAThrl  (t,/,, =  80 rain).  However, the amount recovered in 
the medium is much lower than aAAsnl, ctAThrl, Or ~t-WT; 
only  19 and  17% of the synthesized aAThr2 and t~AAsn2, 
respectively, are recovered. Thus, loss of carbohydrate at po- 
sition 78 by either the Thr or Asn alteration affects the stabil- 
ity of the hCGct subunit resulting in an enhanced degradation 
rate. Moreover, in contrast to ~tAAsnl  and ctAThrl,  the ex- 
tracellular  form of t~AAsn2  and aAThr2  is  heterogeneous 
like ct-WT  (see Discussion). 
The  secretion  kinetics  of  the  deglycosylated  mutants 
ctAAsn(l+2) and ctAThr(l+2) (Fig.  5, F  and G) present a 
different pattern from that seen above. Unlike the fast disap- 
pearance from the  cell of the  wild-type or single  mutated 
subunits, the double mutants are secreted from the cell very 
slowly  (t~  =  6  h)  and  <50%  can  be  recovered  in  the 
medium even after 10 h. We also examined the secretion ki- 
netics of the wild-type ct from cells treated with tunicamycin, 
an  inhibitor of N-linked  glycosylation (Fig.  5  H).  In  this 
case,  as  seen  with  double  mutants,  this  deglycosylated  r 
form is secreted slowly (t,/~ -~ 3 h) and it is also recovered 
quantitatively  in  the  medium.  Thus,  both the  tunicamycin 
deglycosylated et and the mutant ct subunits are slower to exit 
the  cells;  the  small  differences  in  the  rates  and  extent  of 
secretion may be due to indirect effects of tunicamycin on the 
cell or subtle effects of the amino acid substitutions. 
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hCGfl (lanes 1 and 2), aAAsnl and hCGI3 (lanes 3 and 4; lanes 
5 and 6),  ctAThrl and hCGB (lanes  7 and 8;  lanes 9 and 10), 
aAAsn2 and hCG~ (lanes//and 12), ctAThr2  and hCGI3 (lanes 13 
and 14; lanes 15 and 16), ttAAsn(l+2) and hCG[3 (lanes 17and 18), 
and ~tAThr(l+2) and hCG[3 (lanes 19 and 20) were labeled for 8 h. 
The media from each clone were divided into two aliquots and im- 
munoprecipitated with hCGct or hCGI3 antisera. Electrophoresis 
and autoradiography were as described in Materials and Methods. 
Assembly of hCGa Mutants with hCG[3 
To examine subunit assembly of the wild-type hCG[~ subunit 
with  hCGa  and  the  various  mutant  hCGet  subunits, 
pM2CGD  (see  Fig.  1)  was  co-transfected with  pMECGa, 
single mutants, or double mutants.  Clones expressing both 
subunits were then isolated and the ratio of hCGI3 to hCGa 
was determined by immunoprecipitation with either hCGa- 
or hCGl3-specific antisera  (Fig.  6).  For each mutant,  we 
isolated some clones synthesizing excess hCGI3 subunit to 
ensure that the 13 subunit would not be limiting for dimer for- 
mation. Assembly of the various a forms with hCGI~ was as- 
sessed by immunoprecipitation with either an hCGa-specific 
antiserum which recognizes both free hCGot and dimer, or 
with hCGl3-specific antiserum which recognizes both hCGfl 
and hCG dimer. Since hCG~ is in excess, there should be 
equal amounts of a  subunit precipitated by both antisera if 
complete dimerization has occurred. 
Immunoprecipitation of wild-type hCG dimer with either 
a  or 13 antiserum (Fig. 6, lanes 1 and 2) results in recovery 
of equal amounts of the a-WT subunit.  This indicates that 
=100%  of the a  subunit is combined with the hCGI3 in the 
dimer form. In all clones isolated, hCGI~ exits as two forms 
which is due to the addition of one or two N-linked oligosac- 
charides (see reference 29). However, assembly of the gly- 
cosylation site I  mutants  (aAAsnl  and  ctAThrl) with  the 
hCGI~  subunit  is  much  less  efficient.  Although  hCGI3  is 
severalfold in  excess,  <30%  of the  otAAsnl  (clone  11-12, 
lanes 3 and 4) and <10%  of the aAThrl  (clone 6-5, lanes 
7and 8) can assemble into dimers since the total amount of 
a  secreted (lane 3 or 7) is greater than the dimer a  (lane 4 
or 8). Clone 6-14 (lanes 9 and I0) confirms that the lower 
amounts of assembly of the aAThrl mutant vs. the ctAAsnl 
mutant is not peculiar to only one clone hut is representative 
of all mutant r  clones. Moreover, these data suggest 
that different amino acid replacements in this region appear 
to have a small affect unrelated to the absence of sugar.  Even 
when a clone secretes much higher amounts of aAAsnl com- 
parable to a-WT (clone 11-7, lanes 5  and 6), <10%  of the 
hCGI~ is combined with this mutant or aAAsnl  with hCGI~ 
(compare subunits in lanes 5 and 6). A similar situation is 
seen when a clone secreting high amounts of r  is ana- 
lyzed (data not shown). Absence of the oligosaccharide from 
position 52 seems to alter formation of hCG dimer even in 
the presence of excess 13 subunit which is unable to drive the 
dimerization reaction. Alternatively, loss of the oligosaccha- 
ride at this site may affect the stability of the a/fJ complex 
and cause intracellular dimer dissociation. In any case, the 
oligosaccharide at position 52 prevents secretion of intact 
hCG dimer by altering the assembly and/or stability of the 
dimer complex. 
Analysis of clones secreting both hCGI~ and glycosylation 
site II mutants (r  and r  reveals that loss of the 
oligosaccharide of this position has no effect on combina- 
tion. Equal amounts of the mutant subunits are immunopre- 
cipitated by both the a  and 13 antisera from clones 4-6 (lanes 
11 and 12), 7-10 (lanes 13 and 14), and 7-17 (lanes 15 and 16) 
indicating that =100 % of the secreted a  subunit is combined 
with hCGI3. Thus, even though loss of glycosylation site 78 
causes  increased degradation,  it does not affect assembly 
with hCGI3. 
Removal of both glycosylation sites from the a  subunit 
(aAAsn[l+2]  and r  has an intermediate effect 
on assembly with hCGI~. Analysis of clone B-18 (lanes 17 
and 18) reveals that =65% of the total ~tAAsn(l+2) secreted 
is in the form of dimer. Similarly, only =30% of the aAThr- 
(1+2) is secreted as dimer from clone 27-9 (lanes 19and 20). 
These quantitative differences could be due to (a) the approx- 
imately twofold higher levels of hCG~l  in clone  13-18 vs. 
clone 27-9,  which could be driving more ~t to combine or 
Figure 5.  Kinetics of secretion of hCGa wild-type and Asn-glycosylation mutant subunits. CHO clones expressing ot-WT (A), aAAsnl 
(B), ctAThrl (C), 0tAAsn2 (D), aAThr2 (E), aAAsn(l+2) (F), aAThr(l+2) (G), and a-WT treated with tunicamycin (H) were pulse 
labeled for 20 min, chased for the indicated times in Medium III, immunoprecipitated with hCGct antiserum, and prepared as described 
in Materials and Methods. Tunicamycin (2 lag/ml) was present continuously in the preincubation, labeling, and chase media for the ct-WT 
cells shown in H. 
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assembly  of hCGct  site  II  mutants 
with the hCGI3 subunit. CHO clones 
expressing  hCGI3 and  aAAsn2  (A) 
and  hCGI3  and  uAThr2  (B)  were 
treated as described in the legend to 
Fig.  5.  The migration of the hCGct 
site II (a,N-1)  and hCGI~ (13) forms 
in the lysate and medium are shown. 
(b) minor alterations  in the protein backbone,  as seen with 
the  ctAAsnl  and  aAThrl  dimers  discussed  above.  In both 
cases,  though,  the amount of hCG13  is severalfold in excess 
of the deglycosylated 0t mutants and is thus much higher than 
the  ratio  seen  for wild-type  (lanes  1  and  2)  where  =100% 
combination has occurred.  Thus,  removal of both oligosac- 
charides  alters assembly but to a  lesser degree than  loss of 
the oligosaccharide chain at position 52 alone. Treatment of 
dimer-secreting cells with tunicamycin also prevents assem- 
bly of the deglycosylated subunits, although in this case, lack 
of combination may also be due to loss of the two glycosyla- 
tion sites on hCGI3 and  not to loss of the hCGa  sites alone 
(data not  shown). 
Since  ctAAsn2  and  aAThr2  efficiently  combine  with 
hCG13,  these clones were used to determine if the 13 subunit 
might  stabilize  or  protect  these  mutant  a  subunits  from 
degradation.  Clones  4-6  (13/aAAsn2)  and  7-10  (13/ctAThr2) 
were subjected to pulse-chase  analysis as described  above, 
and both media and cell iysate samples were immunoprecipi- 
tated with an a-specific antiserum  (Fig.  7).  The disappear- 
ance of the intracellular  forms of ctAAsn2 (Fig.  7 A, lysate) 
and  aAThr2  (Fig.  7  B,  lysate)  was  identical  and  rapid  (t,/2 
=  60 min). In both cases, hCG13 lacking its O-linked sugars 
is co-precipitated from the lysate with the mutant ct forms al- 
though  at much  lower  levels (Fig.  7,  A and B,  lysate).  The 
appearance of the secreted aAAsn2  and aAThr2  (Fig.  7, A 
and  B,  medium)  is  similar  (t,~  =  60  min),  and  is also ac- 
companied by an equal amount of hCG[3 as seen in Fig.  6. 
Unlike  the  secretion  of free  0tAAsn2  and  aAThr2  where 
<20%  is secreted (Fig.  5, D  and E),  the presence of hCGI3 
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and aAThr2, respectively. Thus, the hCGI3 stabilizes the site 
78 mutants from degradation and allows greater than twofold 
more material to be secreted as dimer. 
Discussion 
Asn-linked oligosaccharides have been implicated in several 
physiologic functions, including the maintenance of intracel- 
lular stability, secretion, receptor binding and biological ac- 
tivity, and modulation of the plasma half-life (see references 
2,  34).  For gonadotropins, the role of the oligosaccharide 
chains in receptor binding and biological activity has been 
examined  extensively  using  chemically  or  enzymatically 
treated hormone (1, 6, 21, 25, 33). Site-directed mutagenesis 
is an effective method to study the oligosaccharide sites on 
multiglycosylated  proteins  since  individual  glycosylation 
sites may have different functions. Here we changed both the 
Asn and Thr residues of the two glycosylation consensus se- 
quences  of hCGc~. This  control is  critical  in  light  of the 
findings of Santos-Aguado et al. (43) which show that differ- 
ent amino acid replacements in the glycosylation recognition 
sequence of HLA-A2 molecules, and not loss of carbohy- 
drate, could affect secretion. 
Site-directed mutagenesis was used to study the two Asn- 
linked oligosaccharides on hCGct and their intracellular role 
in  the  secretion of intact dimer.  Mutagenesis of the Asn- 
linked oligosaccharide at position 52 (ctAAsnl and ttAThrl) 
did not affect the secretion of the mutant subunit; the kinetics 
of secretion  and  recovery  in  the  medium  of the  mono- 
glycosylated form was  identical to wild-type hCGct. Muta- 
genesis of the oligosaccharide at position 78 (ctAAsn2 and 
r  revealed that  the  subunit  was  rapidly  degraded 
and <20%  was  secreted. Loss of this oligosaccharide may 
disrupt folding and/or disulfide bond formation, altering the 
stability of  the peptide and rendering it more sensitive to pro- 
teases. Normally, the oligosaccharide at position 78 of a-WT 
is resistant to Endo F  unless the subunit is denatured first 
(data not shown). Although we do not know the basis for this 
resistance, it is possible that the ct polypeptide folds around 
this oligosaccharide to prevent the endoglycosidase from act- 
ing. This oligosaccharide might then be an important struc- 
tural feature of the ct subunit similar to immunoglobulin mol- 
ecules  where  the  single  oligosaccharide has  been  visibly 
seen to lie in a groove and to play a major role in the interac- 
tion of the Fc and Fad regions (46). An alternative explana- 
tion for this degradation is that removal of the carbohydrate 
unmasks some determinant that directs the position 78 mu- 
tants to another compartment (e.g., lysosomes) where it is 
degraded. 
Removal  of both  glycosylation sites  (ctAAsn[l+2]  and 
r  slows  secretion fourfold but allows =50%  of 
the completely deglycosylated subunits to be secreted. Al- 
though an additive effect might be expected upon removal of 
both glycosylation sites, an intermediate amount of material 
was secreted and at a slower rate. The data suggest an inter- 
dependence of sugar sites-the presence of only one oligo- 
saccharide seems to affect the tertiary structure of the mole- 
cules more than no carbohydrate at all;  differences in the 
folding of the single-site mutants (r  and r  vs. 
the  double-site mutants  might account for the differential 
sensitivity to proteolytic degradation. Because tunicamycin 
prevents addition of all carbohydrates to multiglycosylated 
proteins, it is incapable of revealing this type of interdepen- 
dence. This interdependence is an interesting finding in light 
of the mutagenesis study of the multiglycosylated VSV G 
membrane protein (27).  The absence of the individual gly- 
cosylation sites of VSV G protein has no effect on the secre- 
tion (27), whereas loss of both sites causes aggregation of the 
deglycosylated protein (15, 27). Similarly, aggregation of the 
a  double-site mutants might also account for the differential 
secretion rates of the single and double mutants but cannot 
explain the other differences. These findings for the r  gly- 
cosylation mutants will be useful in understanding the role 
of the  oligosaccharides on other  multiglycosylated mem- 
brane and secretory proteins. 
In pituitary and placenta, hCGa is  secreted in excess of 
hCGI3. The uncombined a subunit is larger and more hetero- 
geneous than dimer-derived a  subunit (the form of r  com- 
bined with I~) (7, 20, 39, 40). Of major interest are the struc- 
tural modifications  responsible for the increased heterogeneity 
of free ct (a*). Corless et al. (9) have shown that in C127 cells 
transfected with hCGct this heterogeneity resides on the Asn- 
linked oligosaccharides and is not due to the presence of an 
O-linked oligosaccharide unit as seen in cultured choriocar- 
cinoma cells (8). The secreted ct-WT and the site 78 mutants 
from CHO cells are more heterogeneous, whereas the se- 
creted site 52 mutants are very homogeneous (Fig. 5). This 
heterogeneity is also seen when the a-WT is secreted from 
CHO cells defective in O-linked glycosylation confirming 
that the heterogeneity resides on the N-linked oligosaccha- 
rides  (data  not  shown).  Although  we  cannot  exclude the 
possibility that mutagenesis of one site can affect terminal 
processing of the other site, the data imply that the oligosac- 
charide at position 52 is likely responsible for ct* heteroge- 
neity. These findings also suggest that the a oligosaccharides 
undergo site-specific carbohydrate processing. 
In  vivo assembly  was  analyzed by coexpression of the 
hCGct wild-type and mutant genes with the wild-type hCGI3 
gene. Whereas >95 % of the secreted wild-type hCGct and 
site II mutant subunits combine with hCGI~, <30% of the site 
I mutants are secreted as dimer, and only =50% of the double 
mutants dimerize. Thus, loss of the oligosaccharide from po- 
sition 52  alters assembly and/or stability of the complex. 
Since the double mutants are secreted slowly, they may have 
a greater chance of interacting with a 13 subunit,  which ac- 
counts for the increased assembly compared to ctAAsnl  and 
r  Differences  in  folding  between  the  single-  and 
double-site mutants  might also  account for the  variations 
seen;  loss of carbohydrate at position 52  may perturb the 
folding of the mutant subunit, and thereby alter a/13 assembly 
without affecting proteolytic stability of  this mutant. Alterna- 
tively, carbohydrate at  position  52  may be present at the 
subunit/subunit interface and thus affect the interaction of the 
a and hCGI3 subunits. Previous studies have shown that car- 
bohydrate-protein interactions are  likely to  be  associated 
with subunit interactions for the neuraminidase tetramer of 
influenza virus  (52)  and  the influenza hemagglutin  trimer 
(54) where carbohydrate has been visualized at subunit inter- 
faces. 
In the presence of hCGIS, site II mutants are stabilized and 
secreted as  intact dimer.  After combination, hCGI3 might 
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that normally causes their degradation.  Alternatively,  hCGI3 
may aid the folding of the ~t subunit.  Gething et al. (14) have 
extensively analyzed the folding process in studies of the in- 
tracellular  transport and assembly of influenza hemaggluti- 
nin molecules.  Similar analyses  will be critical  in under- 
standing (a) the role of hCGct oligosaccharides in the folding 
process and (b) why removal of each oligosaccharide does 
not have an additive effect on the stability  and dimerization 
of the double mutants.  Differences in folding of each mutant 
in the absence of carbohydrate  could account for the varia- 
tions in stability  and assembly  seen for these mutants. 
These mutagenized forms of hCGa should also be useful 
for determining the association of specific oligosaccharides 
to biological activity of hCG. Sairam and Bhargavi (41) used 
chemical deglycosylation of bovine luteinizing hormone and 
follicle-stimulating hormone to examine the role of the oli- 
gosaccharides in the individual subunits.  They showed that 
in contrast to the Asn-linked oligosaccharides on the 13 sub- 
units,  Asn-linked carbohydrates  units on the ct subunit were 
more critical for biological activity.  Only one of the two Asn- 
linked oligosaccharides on hCGa may be necessary for bio- 
logical activity.  That the two oligosaccharides have different 
intracellular  functions (glycosylation site 78 plays a role in 
the integrity  of the hormone, while site 52 is important  for 
assembly of intact hCG molecules) suggests site-specific func- 
tions of the two oligosaccharides on hCGa. Whether this is 
a common feature of other secretory glycoproteins bearing 
multiple glycosylation sites, whether this feature is unique to 
hCGa,  will require  mutagenesis of other glycoproteins. 
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